Hls Therapeutics Stock Market Value
| HLTRF Stock | USD 2.33 0.10 4.12% |
| Symbol | HLS |
HLS Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to HLS Therapeutics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of HLS Therapeutics.
| 10/24/2024 |
| 11/23/2024 |
If you would invest 0.00 in HLS Therapeutics on October 24, 2024 and sell it all today you would earn a total of 0.00 from holding HLS Therapeutics or generate 0.0% return on investment in HLS Therapeutics over 30 days. HLS Therapeutics is related to or competes with Cannara Biotech, Knight Therapeutics, Bionoid Pharma, Crescita Therapeutics, and Centr Brands Corp. HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the sp... More
HLS Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure HLS Therapeutics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess HLS Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 8.68 | |||
| Information Ratio | (0) | |||
| Maximum Drawdown | 23.98 | |||
| Value At Risk | (4.20) | |||
| Potential Upside | 5.41 |
HLS Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for HLS Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as HLS Therapeutics' standard deviation. In reality, there are many statistical measures that can use HLS Therapeutics historical prices to predict the future HLS Therapeutics' volatility.| Risk Adjusted Performance | 0.0375 | |||
| Jensen Alpha | 0.1098 | |||
| Total Risk Alpha | (0.39) | |||
| Sortino Ratio | (0.0005) | |||
| Treynor Ratio | 2.18 |
HLS Therapeutics Backtested Returns
At this point, HLS Therapeutics is very risky. HLS Therapeutics holds Efficiency (Sharpe) Ratio of 0.0391, which attests that the entity had a 0.0391% return per unit of volatility over the last 3 months. We have found twenty-eight technical indicators for HLS Therapeutics, which you can use to evaluate the volatility of the firm. Please check out HLS Therapeutics' market risk adjusted performance of 2.19, and Risk Adjusted Performance of 0.0375 to validate if the risk estimate we provide is consistent with the expected return of 0.13%. HLS Therapeutics has a performance score of 3 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 0.0534, which attests to not very significant fluctuations relative to the market. As returns on the market increase, HLS Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding HLS Therapeutics is expected to be smaller as well. HLS Therapeutics currently retains a risk of 3.35%. Please check out HLS Therapeutics value at risk, as well as the relationship between the skewness and day typical price , to decide if HLS Therapeutics will be following its current trending patterns.
Auto-correlation | 0.03 |
Virtually no predictability
HLS Therapeutics has virtually no predictability. Overlapping area represents the amount of predictability between HLS Therapeutics time series from 24th of October 2024 to 8th of November 2024 and 8th of November 2024 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of HLS Therapeutics price movement. The serial correlation of 0.03 indicates that only 3.0% of current HLS Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.03 | |
| Spearman Rank Test | -0.41 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
HLS Therapeutics lagged returns against current returns
Autocorrelation, which is HLS Therapeutics pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting HLS Therapeutics' pink sheet expected returns. We can calculate the autocorrelation of HLS Therapeutics returns to help us make a trade decision. For example, suppose you find that HLS Therapeutics has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
HLS Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If HLS Therapeutics pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if HLS Therapeutics pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in HLS Therapeutics pink sheet over time.
Current vs Lagged Prices |
| Timeline |
HLS Therapeutics Lagged Returns
When evaluating HLS Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of HLS Therapeutics pink sheet have on its future price. HLS Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, HLS Therapeutics autocorrelation shows the relationship between HLS Therapeutics pink sheet current value and its past values and can show if there is a momentum factor associated with investing in HLS Therapeutics.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in HLS Pink Sheet
HLS Therapeutics financial ratios help investors to determine whether HLS Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HLS with respect to the benefits of owning HLS Therapeutics security.